Literature DB >> 15194184

Pulmonary arterial hypertension: a look to the future.

Lewis J Rubin1, Nazzareno Galiè.   

Abstract

The Third World Symposium on Pulmonary Arterial Hypertension served not only as a forum for the presentation of state-of-the art overviews of the pathobiologic and clinical aspects of pulmonary arterial hypertension (PAH), but also afforded an opportunity to the international scientific community to explore future directions of research and collaboration. This summary provides a brief overview of future directions in the field.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194184     DOI: 10.1016/j.jacc.2004.02.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Authors:  Todd M Bull; Christina A Meadows; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; Serge P Nana-Sinkam; Thomas B Campbell; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

Review 2.  Drug treatment of pulmonary arterial hypertension: current and future agents.

Authors:  Marius M Hoeper
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.

Authors:  Zimeng Wang; Julie L Cuddigan; Sweta K Gupta; Samantha A Meenach
Journal:  Int J Pharm       Date:  2016-08-26       Impact factor: 5.875

4.  Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.

Authors:  Usha Krishnan; Sankaran Krishnan; Michael Gewitz
Journal:  Pediatr Cardiol       Date:  2008-07-02       Impact factor: 1.655

Review 5.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Health-related quality of life in patients with pulmonary arterial hypertension.

Authors:  Darren B Taichman; Jennifer Shin; Laryssa Hud; Christine Archer-Chicko; Sandra Kaplan; Jeffery S Sager; Robert Gallop; Jason Christie; John Hansen-Flaschen; Harold Palevsky
Journal:  Respir Res       Date:  2005-08-10

7.  Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension.

Authors:  Martha Kingman; Christine Archer-Chicko; Mary Bartlett; Joy Beckmann; Robin Hohsfield; Sandra Lombardi
Journal:  Pulm Circ       Date:  2017-07-11       Impact factor: 3.017

Review 8.  Hotspots and frontiers in pulmonary arterial hypertension research: a bibliometric and visualization analysis from 2011 to 2020.

Authors:  Zhen He; Lei Dai; Yuyue Zuo; Yu Chen; Hongjie Wang; Hesong Zeng
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.